Dimerix Management
Management criteria checks 2/4
Dimerix's CEO is Nina Webster, appointed in Aug 2018, has a tenure of 6.33 years. total yearly compensation is A$759.06K, comprised of 49.1% salary and 50.9% bonuses, including company stock and options. directly owns 0.073% of the company’s shares, worth A$139.14K. The average tenure of the management team and the board of directors is 3.5 years and 7.2 years respectively.
Key information
Nina Webster
Chief executive officer
AU$759.1k
Total compensation
| CEO salary percentage | 49.1% |
| CEO tenure | 6.3yrs |
| CEO ownership | 0.07% |
| Management average tenure | 3.5yrs |
| Board average tenure | 7.2yrs |
Recent management updates
Recent updates
We're Interested To See How Dimerix (ASX:DXB) Uses Its Cash Hoard To Grow
Dec 20
Is Dimerix (ASX:DXB) Using Too Much Debt?
Dec 19We're A Little Worried About Dimerix's (ASX:DXB) Cash Burn Rate
Jul 05Can Dimerix (ASX:DXB) Afford To Invest In Growth?
Feb 17We're A Little Worried About Dimerix's (ASX:DXB) Cash Burn Rate
Sep 16We're Keeping An Eye On Dimerix's (ASX:DXB) Cash Burn Rate
Jun 02Most Shareholders Will Probably Agree With Dimerix Limited's (ASX:DXB) CEO Compensation
Sep 20Is Dimerix (ASX:DXB) In A Good Position To Deliver On Growth Plans?
May 17Here's What We Think About Dimerix's (ASX:DXB) CEO Pay
Feb 01CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | AU$759k | AU$373k | -AU$17m |
| Mar 31 2024 | n/a | n/a | -AU$14m |
| Dec 31 2023 | n/a | n/a | -AU$11m |
| Sep 30 2023 | n/a | n/a | -AU$12m |
| Jun 30 2023 | AU$387k | AU$350k | -AU$14m |
| Mar 31 2023 | n/a | n/a | -AU$14m |
| Dec 31 2022 | n/a | n/a | -AU$14m |
| Sep 30 2022 | n/a | n/a | -AU$12m |
| Jun 30 2022 | AU$517k | AU$341k | -AU$10m |
| Mar 31 2022 | n/a | n/a | -AU$10m |
| Dec 31 2021 | n/a | n/a | -AU$9m |
| Sep 30 2021 | n/a | n/a | -AU$7m |
| Jun 30 2021 | AU$408k | AU$334k | -AU$6m |
| Mar 31 2021 | n/a | n/a | -AU$6m |
| Dec 31 2020 | n/a | n/a | -AU$6m |
| Sep 30 2020 | n/a | n/a | -AU$5m |
| Jun 30 2020 | AU$539k | AU$304k | -AU$4m |
| Mar 31 2020 | n/a | n/a | -AU$4m |
| Dec 31 2019 | n/a | n/a | -AU$4m |
| Sep 30 2019 | n/a | n/a | -AU$4m |
| Jun 30 2019 | AU$486k | AU$221k | -AU$3m |
Compensation vs Market: Nina's total compensation ($USD471.85K) is above average for companies of similar size in the Australian market ($USD286.38K).
Compensation vs Earnings: Nina's compensation has increased whilst the company is unprofitable.
CEO
Nina Webster
6.3yrs
Tenure
AU$759,063
Compensation
Dr. Nina Webster, Ph D., BSc (Hons), M IP Law, MBA, has been Chief Executive Offer, Managing Director and Director of Dimerix Limited since August 27, 2018. Dr. Webster served as the Commercial Director of...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Director | 6.3yrs | AU$759.06k | 0.073% A$ 139.1k | |
| Chief Medical Officer | 1.2yrs | AU$361.30k | 0.0033% A$ 6.2k | |
| Chief Commercialisation Officer | 1.1yrs | AU$372.79k | no data | |
| CFO & Company Secretary | 5.9yrs | no data | no data | |
| Chief Scientific Advisor | no data | no data | no data |
3.5yrs
Average Tenure
Experienced Management: DXB's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Director | 6.3yrs | AU$759.06k | 0.073% A$ 139.1k | |
| Non-Executive Chairman | less than a year | AU$52.50k | no data | |
| Independent Non-Executive Director | 7.6yrs | AU$60.00k | no data | |
| Non Executive Director | 9.4yrs | AU$60.00k | 0.10% A$ 190.3k | |
| Member of Medical Advisory Board | 7.2yrs | no data | no data | |
| Member of Medical Advisory Board | 7.2yrs | no data | no data | |
| Member of Medical Advisory Board | 7.2yrs | no data | no data | |
| Member of Medical Advisory Board | 7.2yrs | no data | no data | |
| Non-Executive Director | 1.6yrs | AU$60.00k | no data | |
| Member of ACTION3 Medical Advisory Board | less than a year | no data | no data |
7.2yrs
Average Tenure
Experienced Board: DXB's board of directors are considered experienced (7.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/31 10:32 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dimerix Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|